Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Explore (New York, N.Y.)|November 13, 2012
Patients seek integrative medicine for preventive approach to optimize healthRuth Q Wolever, Donald I Abrams, Benjamin Kligler, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2017
Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network RegistryPaul C Mayor, Kevin H Eng, Kelly L Singel, et al.
Leukemia|February 27, 2020
Inhibition of LSD1 in MDS progenitors restores differentiation of CD141<sup>Hi</sup> conventional dendritic cellsPragya Srivastava, Stephanie L Tzetzo, Eduardo Cortes Gomez, et al.
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
Cell Reports|August 17, 2022
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironmentAthanasios Papadas, Gauri Deb, Alexander Cicala, et al.
Elife|December 9, 2016
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodesAmy W Ku, Jason B Muhitch, Colin A Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal CancerChristos Fountzilas, David L Bajor, Sarbajit Mukherjee, et al.
Annals of Surgical Oncology|September 17, 2025
ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?Jun Arima, Kohei Chida, Rongrong Wu, et al.
Iscience|February 29, 2024
Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progressionStephanie L Tzetzo, Elliot D Kramer, Hemn Mohammadpour, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Explore (New York, N.Y.)|November 13, 2012
Patients seek integrative medicine for preventive approach to optimize healthRuth Q Wolever, Donald I Abrams, Benjamin Kligler, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2017
Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network RegistryPaul C Mayor, Kevin H Eng, Kelly L Singel, et al.
Leukemia|February 27, 2020
Inhibition of LSD1 in MDS progenitors restores differentiation of CD141<sup>Hi</sup> conventional dendritic cellsPragya Srivastava, Stephanie L Tzetzo, Eduardo Cortes Gomez, et al.
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
Cell Reports|August 17, 2022
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironmentAthanasios Papadas, Gauri Deb, Alexander Cicala, et al.
Elife|December 9, 2016
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodesAmy W Ku, Jason B Muhitch, Colin A Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal CancerChristos Fountzilas, David L Bajor, Sarbajit Mukherjee, et al.
Annals of Surgical Oncology|September 17, 2025
ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?Jun Arima, Kohei Chida, Rongrong Wu, et al.
Iscience|February 29, 2024
Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progressionStephanie L Tzetzo, Elliot D Kramer, Hemn Mohammadpour, et al.
Pageof 38